HPV vaccines have significantly reduced cervical cancer incidence, with studies showing an 87% reduction in invasive cervical cancer among young women vaccinated at ages 12-13 and an 88% reduction in HPV infections among 14-19 year-old females within 12 years of vaccine introduction.